Share-based Payment Arrangement, Expense in USD of PROKIDNEY CORP. from 2020 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Prokidney Corp. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2020 to Q3 2025.
  • Prokidney Corp. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2025 was $6.68M, a 3.74% decline year-over-year.
  • Prokidney Corp. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2025 was $26.6M, a 65.6% increase year-over-year.
  • Prokidney Corp. annual Share-based Payment Arrangement, Expense for 2024 was $29.4M, a 4.78% decline from 2023.
  • Prokidney Corp. annual Share-based Payment Arrangement, Expense for 2023 was $30.8M, a 58.6% decline from 2022.
  • Prokidney Corp. annual Share-based Payment Arrangement, Expense for 2022 was $74.5M, a 10554% increase from 2021.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)

PROKIDNEY CORP. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $26.6M $6.68M -$259K -3.74% Jul 1, 2025 Sep 30, 2025 10-Q 2025-11-10
Q2 2025 $26.8M $6.54M -$1.27M -16.2% Apr 1, 2025 Jun 30, 2025 10-Q 2025-08-12
Q1 2025 $28.1M $6.42M -$1.26M -16.5% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-12
Q4 2024 $29.4M $6.95M +$13.3M Oct 1, 2024 Dec 31, 2024 10-K 2025-03-17
Q3 2024 $16.1M $6.93M -$6.06M -46.6% Jul 1, 2024 Sep 30, 2024 10-Q 2025-11-10
Q2 2024 $22.1M $7.81M -$3.39M -30.3% Apr 1, 2024 Jun 30, 2024 10-Q 2025-08-12
Q1 2024 $25.5M $7.68M -$5.34M -41% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-12
Q4 2023 $30.8M -$6.37M -$15.3M -171% Oct 1, 2023 Dec 31, 2023 10-K 2025-03-17
Q3 2023 $46.2M $13M +$8.15M +168% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 $38M $11.2M +$3.2M +40% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-09
Q1 2023 $34.8M $13M -$39.7M -75.3% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-10
Q4 2022 $74.5M $8.94M Oct 1, 2022 Dec 31, 2022 10-K 2025-03-17
Q3 2022 $4.84M +$4.84M Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 $8M Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 $52.7M Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q3 2021 $0 Sep 30, 2021 10-Q 2021-11-15
Q3 2021 $175K Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14

PROKIDNEY CORP. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $29.4M -$1.47M -4.78% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-17
2023 $30.8M -$43.6M -58.6% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-17
2022 $74.5M +$73.8M +10554% Jan 1, 2022 Dec 31, 2022 10-K 2025-03-17
2021 $699K -$31K -4.25% Jan 1, 2021 Dec 31, 2021 10-K 2024-03-22
2020 $730K Jan 1, 2020 Dec 31, 2020 10-K 2023-03-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.